Neurofibromas are benign tumors comprised primarily of Schwann cells and fibroblasts. Mast cell infiltration is a well-known phenomenon; however, their role in tumor pathogenesis has been enigmatic. In an elegant set of experiments using cells derived from a murine model of neurofibromatosis 1 (NF1), Yang et al. dissect the molecular pathways involved in mast cell migration to neurofibromin-deficient Schwann cells. These results set the stage for rational development of therapeutics that could influence the multicellular microenvironment of neurofibromas to inhibit the development and/or progression of these tumors in human NF
David H. Viskochil
Title and authors | Publication | Year |
---|---|---|
Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model
McLean DT, Meudt JJ, Lopez Rivera LD, Schomberg DT, Pavelec DM, Duellman TT, Buehler DG, Schwartz PB, Graham M, Lee LM, Graff KD, Reichert JL, Bon-Durant SS, Konsitzke CM, Ronnekleiv-Kelly SM, Shanmuganayagam D, Rubinstein CD |
Frontiers in Oncology | 2023 |
An Unusual Intraosseous Swelling of the Jaw: Two Rare Case Reports.
Jain R, Gosavi S, Sethia D, Trimuke A |
2023 | |
After Nf1 loss in Schwann cells, inflammation drives neurofibroma formation
JS Fletcher, J Pundavela, N Ratner |
2019 | |
Cutaneous neurofibromas in the genomics era: current understanding and open questions
RJ Allaway, SJ Gosline, SL Rosa, P Knight, A Bakker, J Guinney, LQ Le |
British Journal of Cancer | 2018 |
Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
VW Keng, AL Watson, EP Rahrmann, H Li, BR Tschida, BS Moriarity, K Choi, TA Rizvi, MH Collins, MR Wallace, N Ratner, DA Largaespada |
Sarcoma | 2012 |
The Plexiform Neurofibroma Microenvironment
FC Yang, K Staser, DW Clapp |
Cancer Microenvironment | 2012 |
PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors.
Keng VW, Rahrmann EP, Watson AL, Tschida BR, Moertel CL, Jessen WJ, Rizvi TA, Collins MH, Ratner N, Largaespada DA |
Cancer research | 2012 |
Occipital peripheral nerve stimulation in the management of chronic intractable occipital neuralgia in a patient with neurofibromatosis type 1: a case report.
Skaribas I, Calvillo O, Delikanaki-Skaribas E |
Journal of medical case reports | 2011 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Solitary fibrous tumor of the oral cavity: clinicopathologic and immunohistochemical study of 21 cases.
O'Regan EM, Vanguri V, Allen CM, Eversole LR, Wright JM, Woo SB |
Head and Neck Pathology | 2009 |
Neuro-oncology of Neurofibromatosis Type 1.
Hottinger AF, Khakoo Y |
Current Treatment Options in Neurology | 2009 |
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells
AS McDaniel, JD Allen, SJ Park, ZM Jaffer, EG Michels, SJ Burgin, S Chen, WK Bessler, C Hofmann, DA Ingram, J Chernoff, DW Clapp |
Blood | 2008 |
Midline cutaneous lumbosacral lesions: not always a sign of occult spinal dysraphism.
Martínez-Lage JF, Niguez BF, Pérez-Espejo MA, Almagro MJ, Maeztu C |
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery | 2006 |